High CD34 cell doses do not worsen regimen-related toxicity or early mortality after autologous blood stem cell transplantation for breast cancer

Autor: Braunschweig, I., Mirza, N.Q., Rondon, G., Lauppe, J., Mehra, R., Gajewski, J., Korbling, M., Huh, Y.O., Geisler, D., Gee, A.P., Champlin, R., Przepiorka, D.
Zdroj: In Cytotherapy February 2000 2(2):105-110
Databáze: ScienceDirect